Senseonics Holdings, Inc. operates as a medical technology company. The Company focuses on the design, development, and commercialization of glucose monitoring systems. Senseonics Holdings conducts business in the United States.

S-3 | Registration statement for specified transactions by certain issuers

Current Report (Form 8-K | Period ending 2024-11-19)

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Senseonics Holdings (SENS US)

S-3 | Registration statement for specified transactions by certain issuers

Current Report (Form 8-K | Period ending 2024-11-19)

Quarterly Report (Form 10-Q | Period ending 2024-09-30)

Current Report (Form 8-K | Period ending 2024-11-07)

Current Report (Form 8-K | Period ending 2024-10-24)

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)